SCHEMBL1955823

SCHEMBL1955823

CC1(C)CCC(CN2CCN(c3ccc(C(=O)N[S+]([O-])c4ccc(OCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4ccc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 3/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1959045 0.92 BCL2 (0.83) BCL2
SCHEMBL1957665 0.90 BCL2 (0.69) BCL2
SCHEMBL1955269 0.90 BCL2 (0.87) BCL2
SCHEMBL1957655 0.89 BCL2 (0.69) BCL2
SCHEMBL1958650 0.89 BCL2 (0.71) BCL2
SCHEMBL1869537 0.89 BCL2 (0.76) BCL2
SCHEMBL1871809 0.88 BCL2 (0.74) BCL2
SCHEMBL1958125 0.87 BCL2 (0.82) BCL2
SCHEMBL1959174 0.86 BCL2 (0.83) BCL2
SCHEMBL1955172 0.86 BCL2 (0.74) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507229-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 — — EP disclosed
WO-2011068561-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-06-09 — — WO disclosed
Send feedback